You Searched For "ceo adar poonawalla" and got 20 results
Sort By:
Adar Poonawalla gets 50% stake in Karan Johar's Dharma Productions for ₹1,000 crore
Adar Poonawalla’s Serene Productions acquires a 50% stake in Karan Johar’s Dharma Productions and D…
Govt likely to float global tender for HPV vaccine in April; Merck, Serum Institute may participate
The Health Ministry intends to roll out HPV vaccine against cervical cancer in the national immunis…
PTI
Global rollout of 12 billion Covid-19 vaccine doses largest-ever, but access is an issue: WHO
Addressing the annual general meeting of the Developing Countries Vaccine Manufacturers Network …
Serum Institute to roll out COVID-19 vaccine for children in six months, says CEO Adar Poonawalla
"We haven't seen a lot of severe disease in children. Fortunately, the panic is not there fo…
PTI
Rivals Serum Institute and Bharat Biotech come together after fear of ban on vaccine exports
Bharat Biotech CEO Krishna Ella and Serum Institute of India (SII) CEO Adar Poonawalla issued a joi…
India has its eyes and hopes pinned on Adar Poonawalla— the world’s biggest vaccine maker who will be speaking at the Global Trends Festival 2020
If developing a vaccine for COVID-19 virus is the most important thing, the 39-year old Adar Poonaw…
SII CEO believes 'vaccine nationalism' in India and the US could derail efforts to deliver two billion doses to poorer nations
Adar Poonawalla, CEO, Serum Institute of India (SII) has said that vaccine nationalism in countries…
COVID-19 vaccine will be priced at ₹1,000 and would be available by February for healthcare workers and elderly people, says Serum CEO Adar Poonawalla
"It will probably take two or three years for every Indian to get inoculated, not just because o…
PTI
Biocon Biologics to offer 15% stake to Serum Institute Life Sciences at valuation of $4.9 billion
In addition to vaccines, the strategic alliance will also develop antibodies targeting seve…
PTI
Serum Institute CEO says vaccine development is like rollercoaster
"Developing a vaccine is like riding a rollercoaster; there are plenty of ups and downs. Sometim…
US-based biotechnology company Novavax’s COVID-19 shot is 90% effective
US-based biotechnology company Novavax's protein-based vaccine has shown overall 90 per cent effica…
SII’s Adar Poonawalla estimates two more months of COVID-19 vaccine shortage in India — and the blame game is heating up
Not only has the number of COVID-19 cases surging in the world’s second most populous country but t…
The leader of one of the world's biggest vaccine manufacturers said he fled India because of menacing threats
Adar Poonawalla told The Times of London he faced an "unprecedented" environment of "expectation an…
Yelena Dzhanova
Adar Poonawalla's Serum cuts Covishield vaccine price for state governments to ₹300 a dose after much backlash
In a tweet, Poonawalla called this cut a "philanthropic gesture" that will save crores of rupees…
If 2015 was the ‘Year of the API’, why is there a Remdesivir shortage six years later?
Catchphrases don’t cure, actual drugs do. In fact, since 2015, the year when the government…
Serum Institute's second COVID-19 vaccine 'Covavax' likely to be launched in September
Serum Institute of India, the world's biggest Covid-19 vaccine maker, is hopeful to launch Covovax …
Coronavirus vaccine Covishield completes enrolment of phase-3 clinical trials under ICMR, Serum Institute's partnership
"The partnership is a stellar example of private-public institutes collaborating to mitigate the…
PTI
SII's Adar Poonawalla says it will take 2-3 years for the entire world population to get fully vaccinated
Serum Institute of India CEO Adar Poonawalla has said that the SII never exported vaccines at the c…
Benefits and extra attractions for the attendees of the Business Insider Global Trends Festival
The attendees of the Business Insider Global Trends Festival conference are getting several benefit…
The success story of Cyrus Poonawalla: The vaccine king who is one of the world’s richest billionaires
India’s vaccine king tried to make an affordable Jaguar but chose to go for a ‘product of the masse…